Discounted Cash Flow

Akari Therapeutics Plc. ADR

AKTX · Based on 10 years of SEC filings · Converted from GBP to USD (52312 ordinary shares per ADR)

—

Cash flow predictability 70/100 (stable) — FCF YoY std dev 27%, net income 50% (full history)

Average annual growth rates

Metric	10-Year	5-Year	3-Year
Sales	—	—	—
Free Cash Flow	—	—	—
Average (FCF & NI)	—	—	—
Net Income	—	—	—
Dividends	—	—	—

Average annual growth is the mean year-over-year change across each period.

Endpoint CAGR (better for long term trend)

Metric	10-Year	5-Year	3-Year
Sales	—	—	—
Free Cash Flow	—	—	—
Average (FCF & NI)	—	—	—
Net Income	—	—	—

Endpoint CAGR is the compound annual rate from the first to last year in each period.

Projections use average year-over-year growth. Change this in Settings.

Projected growth rate

—

Free cash flow growth —

10-year: — 5-year: — 3-year: —

Averaged growth (FCF & NI) —

10-year: — 5-year: — 3-year: —

Net income growth —

10-year: — 5-year: — 3-year: —

Sales growth (not added to calculations) —

10-year: — 5-year: — 3-year: —

Click a greyed-out slider to switch metrics. Slide between the 10-year, 5-year, and 3-year historic growth rates for FCF, net income, or their average.

Or enter your own rate

Inflation rate (used with B/E only)

Historical inputs (10 fiscal years)

YEAR	Sales	Net Income	Free Cash Flow	Net Margin	EPS (diluted)
2016	—	$-24.5m	$-33.4m	—	—
2017	—	$-47.9m (-95.1%)	$-42.8m (-28.2%)	—	—
2018	—	$-22.3m (53.5%)	$-30.5m (28.6%)	—	—
2019	—	$-23.1m (-3.9%)	$-17.5m (42.8%)	—	$-0.01
2020	—	$-23.1m (0.1%)	—	—	$-0.01 (0.0%)
2021	—	$-23.6m (-2.0%)	—	—	$0.00 (100.0%)
2022	—	$-24.0m (-1.9%)	—	—	$0.00
2023	—	$-13.5m (43.6%)	$-22.2m	—	$0.00
2024	—	$-26.8m (-97.8%)	$-17.0m (23.6%)	—	$0.00
2025	—	$-23.4m (12.6%)	$-14.3m (15.8%)	—	$0.00

Base FCF: — (latest fiscal year)

Discount rate: %

Terminal growth: —

Projection period: — years

Alt A decline yrs:

Alt B total yrs:

SEC filings report in GBP. Values above are converted to USD for comparison with the US-listed share price.

Projected cash flows

Year	Projected cash flow	Discount Factor	Present Value

PV of projected FCF: —

Terminal FCF: —

Terminal value: —

PV of terminal value: —

Enterprise value (DCF): —

Current price: —

Alternative DCF Models

Model	Fair Value	Upside	PV(FCFs)	PV(Terminal)	Total Years
Standard (10yr→TV) ⓘ	—	—	—	—	10 + TV
Alt A (Gradual Decline) ⓘ	—	—	—	—	—
Alt B (30yr Hard Stop) ⓘ	—	—	—	N/A	—

This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.

+ 10YR Financials Balance Sheet (10YR) Cash Flow (10YR) DCF Model